NSCIF News Today: Stay Updated with the Latest Nanalysis Scientific Corp. News in Real Time
Find NSCIF news now at Meyka AI. Stay informed with the latest Nanalysis Scientific Corp. stocks updates, including price news, market analysis, and expert insights.
Oracle Corp (NYSE: ORCL) Dips Ahead of Q4 Earnings: $553B AI Backlog Is the Number That Matters Most
The market is holding its breath. Oracle Corp (NYSE: ORCL) reports fiscal Q4 2026 results after the market closes on June 10, 2026, with a conference call and webcast scheduled for 5:00 PM ET. ORCL traded between a session low of $197.79 and a high of $220.50 on June 10, with the stock sitting at…
Markets Under Pressure Ahead of CPI Report as Inflation Forecast Hits 4.2% and Brent Crude Rises to $93
Global markets turned cautious on June 10, 2026, as investors awaited the latest U.S. Consumer Price Index (CPI) report. Economists expect inflation to rise to 4.2%, while Brent crude oil has climbed to around $93 per barrel, adding fresh pressure on prices across the economy. These developments have increased concerns about future interest rate decisions…
NVIDIA Corp (NVDA -0.22% / -1.78% Pre-Market) Leads AI Chip Stocks Drop as AMD (-3.02%), Intel (-2.13%), and Micron (-1.41%) Decline
NVIDIA shares fell 1.78% in pre-market trading on June 10, 2026, leading a broader decline across AI chip stocks. AMD dropped 3.02%, while Intel and Micron also traded lower as investors reacted to renewed concerns over inflation, interest rates, and technology valuations. The selloff comes after a powerful AI-driven rally that pushed semiconductor stocks to…
Toyota Motor Corp (TYO: 7203) Slips 0.57% (-16 JPY) After Filing Latest Securities Report in Japan
Toyota Motor Corp shares declined 0.57% or 16 JPY in recent trading after the company submitted its latest securities report in Japan. While the decline was relatively modest, investors closely monitored the filing for insights into the automaker’s financial position, business strategy, and future growth outlook. The movement reflects the cautious sentiment currently present across…
Intel Corp (NASDAQ: INTC) Shares Drop 2.1% as Stock Falls to $99.46 Before Closing at $107.92
Intel Corp (NASDAQ: INTC) saw a volatile trading session, reflecting mixed investor sentiment in the semiconductor space. Shares of Intel Corp dropped around 2.1% during the session, falling as low as $99.46 before recovering and closing stronger at $107.92. This kind of price action shows something important. The market is not moving in one direction….
Lindy Chamberlain Calls for Jury System Reform, June 10
Lindy Chamberlain advocates for jury system reform following her wrongful conviction, citing jurors’ lack of forensic evidence understanding.
Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally
Parabilis Medicines is aiming for a valuation of nearly $2.3 billion through an expanded U.S. initial public offering, highlighting renewed investor confidence in the biotechnology sector. The Cambridge, Massachusetts-based company increased the size of its offering as demand for biotech IPOs continues to improve following a challenging period for the industry. The company now plans…
Trump’s Proposed $100,000 H-1B Visa Fee Struck Down; What It Means for Indian Professionals
A major development in U.S. immigration policy has brought relief to thousands of skilled foreign workers and employers. A federal judge has struck down former President Donald Trump’s proposed $100,000 H-1B Visa fee, ruling that the administration lacked the legal authority to impose such a charge without approval from Congress. The ruling came from U.S….
Eli Lilly Stock (LLY) Jumps 4% to $1,131.42 USD as Retatrutide Cuts Sleep Apnea by 60% in Phase 3 Trial
Eli Lilly stock gained approximately 4 percent and climbed to $1,131.42 USD after the company announced promising Phase 3 clinical trial results for Retatrutide. The experimental drug demonstrated a remarkable ability to reduce obstructive sleep apnea severity by nearly 60 percent, generating excitement among investors and healthcare professionals. The announcement strengthened confidence in Eli Lilly’s…